The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.
ConditionAneurysm Cerebral
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-85
SponsorJacobs institute
About this trial
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subject has a single untreated target IA.
Disqualifiers
Subject with anatomy not appropriate for endovascular treatment.
Trial design
Design model
Single group
Treatments tested in this trial
Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy.
Devicemedial device intervention for aneurysm cerebral.
Treatment groups
15 Participants
are divided into 1 treatment groupGroup A: Single arm study for a medical device for the FREDX device for aneurysm cerebral treatment with DAPTExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
A thromboembolic event in the territory supplied by the treated artery.
A thromboembolic event in the territory supplied by the treated artery.
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Jacobs institute
Lead sponsor
University at Buffalo
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: